These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25203958)

  • 1. Angiogenesis as a therapeutic target in endometriosis.
    Djokovic D; Calhaz-Jorge C
    Acta Med Port; 2014; 27(4):489-97. PubMed ID: 25203958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal models for anti-angiogenic therapy in endometriosis.
    Edwards AK; Nakamura DS; Virani S; Wessels JM; Tayade C
    J Reprod Immunol; 2013 Mar; 97(1):85-94. PubMed ID: 23432875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calligonum comosum (Escanbil) extract exerts anti-angiogenic, anti-proliferative and anti-inflammatory effects on endometriotic lesions.
    Kiani K; Rudzitis-Auth J; Scheuer C; Movahedin M; Sadati Lamardi SN; Malekafzali Ardakani H; Becker V; Moini A; Aflatoonian R; Ostad SN; Menger MD; Laschke MW
    J Ethnopharmacol; 2019 Jul; 239():111918. PubMed ID: 31034955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-angiogenic treatment strategies for the therapy of endometriosis.
    Laschke MW; Menger MD
    Hum Reprod Update; 2012; 18(6):682-702. PubMed ID: 22718320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis.
    Rudzitis-Auth J; Menger MD; Laschke MW
    Hum Reprod; 2013 May; 28(5):1339-47. PubMed ID: 23427233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis and antiangiogenic therapy in endometriosis.
    Becker CM; D'Amato RJ
    Microvasc Res; 2007; 74(2-3):121-30. PubMed ID: 17574280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic mechanisms of vascularization in endometriosis and their clinical implications.
    Laschke MW; Menger MD
    Hum Reprod Update; 2018 Mar; 24(2):207-224. PubMed ID: 29377994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plants as source of new therapies for endometriosis: a review of preclinical and clinical studies.
    Meresman GF; Götte M; Laschke MW
    Hum Reprod Update; 2021 Feb; 27(2):367-392. PubMed ID: 33124671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometriosis and angiogenesis.
    May K; Becker CM
    Minerva Ginecol; 2008 Jun; 60(3):245-54. PubMed ID: 18547987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis.
    Novella-Maestre E; Carda C; Noguera I; Ruiz-Saurí A; García-Velasco JA; Simón C; Pellicer A
    Hum Reprod; 2009 May; 24(5):1025-35. PubMed ID: 19189995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-γ by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions.
    Nenicu A; Körbel C; Gu Y; Menger MD; Laschke MW
    Hum Reprod; 2014 May; 29(5):1011-24. PubMed ID: 24578472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenic therapies in endometriosis.
    Ferrero S; Ragni N; Remorgida V
    Br J Pharmacol; 2006 Sep; 149(2):133-5. PubMed ID: 16894342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Novel Medical Nonhormonal Treatments on the Angiogenesis of Endometriotic Lesions.
    Thanatsis N; Filindris T; Siampalis A; Papageorgiou E; Panagodimou E; Adonakis G; Kaponis A
    Obstet Gynecol Surv; 2021 May; 76(5):281-291. PubMed ID: 34032860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice.
    Wang CC; Xu H; Man GC; Zhang T; Chu KO; Chu CY; Cheng JT; Li G; He YX; Qin L; Lau TS; Kwong J; Chan TH
    Angiogenesis; 2013 Jan; 16(1):59-69. PubMed ID: 22948799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural therapies assessment for the treatment of endometriosis.
    Ricci AG; Olivares CN; Bilotas MA; Bastón JI; Singla JJ; Meresman GF; Barañao RI
    Hum Reprod; 2013 Jan; 28(1):178-88. PubMed ID: 23081870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What is new about endometriosis?].
    Dupas C; Christin-Maitre S
    Ann Endocrinol (Paris); 2008 Sep; 69 Suppl 1():S53-6. PubMed ID: 18954860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-alpha,25-dihydroxyvitamin D3 regresses endometriotic implants in rats by inhibiting neovascularization and altering regulation of matrix metalloproteinase.
    Yildirim B; Guler T; Akbulut M; Oztekin O; Sariiz G
    Postgrad Med; 2014 Jan; 126(1):104-10. PubMed ID: 24393757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Anti-VEGF/VEGFR Agents on Animal Models of Endometriosis: A Systematic Review and Meta-Analysis.
    Liu S; Xin X; Hua T; Shi R; Chi S; Jin Z; Wang H
    PLoS One; 2016; 11(11):e0166658. PubMed ID: 27855197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenic properties of endometrial mesenchymal stromal cells in endothelial co-culture: an in vitro model of endometriosis.
    Canosa S; Moggio A; Brossa A; Pittatore G; Marchino GL; Leoncini S; Benedetto C; Revelli A; Bussolati B
    Mol Hum Reprod; 2017 Mar; 23(3):187-198. PubMed ID: 28158750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of dual specificity phosphatase-2 by hypoxia promotes interleukin-8-mediated angiogenesis in endometriosis.
    Hsiao KY; Chang N; Lin SC; Li YH; Wu MH
    Hum Reprod; 2014 Dec; 29(12):2747-55. PubMed ID: 25316445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.